ResearcherAnhui Medical UniversityNo recent work listed

Xi Ou

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5019722977. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper

Papers 2

LASSO regression combined with SVM-REF to screen the characteristic genes of pancreatic cancer and its immune correlation analysis Last author DOI 10.21203/rs.3.rs-2251290/v1 ↗
Desumoylating Isopeptidase 2 (DESI2) Inhibits Proliferation and Promotes Apoptosis of Pancreatic Cancer Cells through Regulating PI3K/AKT/mTOR Signaling Pathwa… Co-author DOI 10.1007/s12253-018-0487-4 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

yiyang chen · 1 shared paper, 2022 · strength 0.22
- Paper LASSO regression combined with SVM-REF to screen the characteristic genes of pancreatic cancer and its immune correlati… DOI 10.21203/rs.3.rs-2251290/v1 ↗
Jikui Liu · 1 shared paper, 2019 · strength 0.11
- Paper Desumoylating Isopeptidase 2 (DESI2) Inhibits Proliferation and Promotes Apoptosis of Pancreatic Cancer Cells through R… DOI 10.1007/s12253-018-0487-4 ↗
Xiaoping Liu · 1 shared paper, 2019 · strength 0.11
- Paper Desumoylating Isopeptidase 2 (DESI2) Inhibits Proliferation and Promotes Apoptosis of Pancreatic Cancer Cells through R… DOI 10.1007/s12253-018-0487-4 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.